BOSTON--(BUSINESS WIRE)--
NeuroMetrix, Inc. (NASDAQ:NURO) today announced that its Quell Wearable
Pain Relief Technology will be exhibited at the Pri-Med East Annual
Conference in Boston on September 18-20, 2015. The Pri-Med East Annual
Conference curriculum is developed with the American College of
Physicians and is an important source of education for primary care
physicians and other healthcare professionals on a wide range of
therapeutic topics and the latest treatments and therapies. Over 4000
persons are expected to attend.
"Primary care physicians are at the frontline of treating chronic
conditions," said Shai N. Gozani, M.D., Ph.D. President and CEO of
NeuroMetrix, Inc. "Quell represents a new option for them in helping
their patients manage chronic pain conditions such as painful diabetic
neuropathy, sciatica, arthritis and fibromyalgia."
About Quell Wearable Pain Relief Device
Quell is an easy-to-use, over-the-counter device for relief of chronic
pain. This wearable device utilizes NeuroMetrix's wearable intensive
nerve stimulation (WINS) technology to provide pain relief. In a recent
clinical study, Quell was shown to improve chronic pain and overall
health in 81% of participants. Quell is currently available through
select healthcare professionals, retailers and online at www.QuellRelief.com.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150915005459/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
